Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-8-16
pubmed:abstractText
Cardiomyopathy is a heart muscle disease with impaired stretch response that can result in severe heart failure and sudden death. A small proportion of hepatitis C virus (HCV)-infected patients may be predisposed to develop dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM). The molecular mechanisms involved in the predisposition remain unknown due in part to the lack of information on their genetic background. Because the human leukocyte antigen (HLA) region has a pivotal role in controlling the susceptibility to HCV-induced liver disease, we hypothesized that particular HLA alleles and/or non-HLA gene alleles within the human major histocompatibility complex (MHC) genomic region might control the predisposition to HCV-associated DCM (HCV-DCM) and/or HCV-associated HCM (HCV-HCM). Here, we present mapping results of the MHC-related susceptibility gene locus for HCV-associated cardiomyopathy by analyzing microsatellite and single nucleotide polymorphism markers. To delineate the susceptibility locus, we genotyped 44 polymorphic markers scattered across the entire MHC region in a total of 59 patients (21 HCV-DCM and 38 HCV-HCM) and 120 controls. We mapped HCV-DCM susceptibility to a non-HLA gene locus spanning from NFKBIL1 to MICA gene loci within the MHC class III-class I boundary region. Our results showed that HCV-DCM was more strongly associated with alleles of the non-HLA genes rather than the HLA genes themselves. In addition, no significant association was found between the MHC markers and HCV-HCM. This marked difference in the MHC-related disease susceptibility for HCV- associated cardiomyopathy strongly suggests that the development of HCV- DCM and HCV-HCM is under the control of different pathogenic mechanisms.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/DDX39B protein, human, http://linkedlifedata.com/resource/pubmed/chemical/DEAD-box RNA Helicases, http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers, http://linkedlifedata.com/resource/pubmed/chemical/HLA Antigens, http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I, http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II, http://linkedlifedata.com/resource/pubmed/chemical/MHC class I-related chain A, http://linkedlifedata.com/resource/pubmed/chemical/MICB antigen, http://linkedlifedata.com/resource/pubmed/chemical/NFKBIL1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/RNA Helicases, http://linkedlifedata.com/resource/pubmed/chemical/Vacuolar Proton-Translocating...
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0001-2815
pubmed:author
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
200-8
pubmed:dateRevised
2011-10-17
pubmed:meshHeading
pubmed-meshheading:16101831-Alleles, pubmed-meshheading:16101831-Cardiomyopathy, Dilated, pubmed-meshheading:16101831-Cardiomyopathy, Hypertrophic, pubmed-meshheading:16101831-Chromosome Mapping, pubmed-meshheading:16101831-DEAD-box RNA Helicases, pubmed-meshheading:16101831-DNA Primers, pubmed-meshheading:16101831-Genetic Predisposition to Disease, pubmed-meshheading:16101831-Genome, pubmed-meshheading:16101831-Genotype, pubmed-meshheading:16101831-HLA Antigens, pubmed-meshheading:16101831-Haplotypes, pubmed-meshheading:16101831-Hepacivirus, pubmed-meshheading:16101831-Histocompatibility Antigens Class I, pubmed-meshheading:16101831-Histocompatibility Antigens Class II, pubmed-meshheading:16101831-Humans, pubmed-meshheading:16101831-Linkage Disequilibrium, pubmed-meshheading:16101831-Microsatellite Repeats, pubmed-meshheading:16101831-Models, Genetic, pubmed-meshheading:16101831-Odds Ratio, pubmed-meshheading:16101831-Polymorphism, Single Nucleotide, pubmed-meshheading:16101831-Promoter Regions, Genetic, pubmed-meshheading:16101831-RNA Helicases, pubmed-meshheading:16101831-Risk, pubmed-meshheading:16101831-Treatment Outcome, pubmed-meshheading:16101831-Vacuolar Proton-Translocating ATPases
pubmed:year
2005
pubmed:articleTitle
The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.
pubmed:affiliation
Department of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't